Top Markets
#1 ADO Protocol ADO Protocol +329.28%
#2 GoPlus Security GoPlus Security +51.99%
#3 Nockchain Nockchain +44.89%
#4 Tutorial Tutorial +37.01%
#5 Starpower Starpower +35.10%
#6 The Black Bull The Black Bull +32.84%
#7 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +31.02%
#8 GAIB AID GAIB AID +24.67%
#9 Verus Coin Verus Coin +20.20%
#10 Casper Network Casper Network +16.87%
Coin of the day
ADO Protocol ADO Protocol
Settings
Language
ENGLISH
Currency
USD
Theme
Arctic Bioscience AS Arctic Bioscience AS

Arctic Bioscience AS

ABS
Rank in Stocks #33049
Arctic Bioscience AS, a clinical-stage biotechnology company, engages in... Arctic Bioscience AS, a clinical-stage biotechnology company, engages in developing and commercializing pharmaceutical and nutraceutical ingredients based on bioactive marine compounds in Norway, the United States, Europe, and Asia Pacific. The company is developing HRO350, a novel oral drug which is in phase IIb for the treatment of mild-to-moderate psoriasis. It also sells nutraceuticals as intermediary and finished goods products under the ROMEGA brand name. Arctic Bioscience AS was incorporated in 2011 and is headquartered in Ørsta, Norway.
Share Price
$0.3144463
Market Cap
$8.48M
Change (1 day)
0.00%
Change (1 year)
-2.55%
Country
NO
Trade Arctic Bioscience AS (ABS)

Category

Healthcare
Earnings for Arctic Bioscience AS (ABS)
Earnings in 2026 TTM: 0
According to Arctic Bioscience AS latest financial reports the company's current earnings are 0. In 2026 the company made an earning of 0, equal to its 2026 earnings that were of 0. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Arctic Bioscience AS from 2026 to 2026
Earnings at the end of each year
Year Earnings Change
Not enough data for the provided dates.
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B -
BE